Rafael Holdings RFL Q1 2025 Results Meet Expectations Revenue NA April Jobs Report Shows Cooling but Resilient Labor Market XTI Aerospace XTIA Q1 2026 Earnings Miss Sparks Concern Jim Cramer on NVIDIA Valuation Narrows Gap as AI Titan Gains Momentum European Commission Fines Temu 200 Million Over Illegal and Dangerous Product Sales Micron Shares Surge Toward Best Month Since 1987 Analysts See Value Play PutinXi Talks Advance Stalled Power of Siberia 2 Gas Pipeline Amid Iran War Energy Market Turmoil ConocoPhillips Cash Flow Focus Remains Key Amid LNG Development Activity Borosil Glass Works Surges Over 200 in One Year Whats Driving the Momentum Nvidia AMD and Broadcom A Comparative Look at AI Chip Leaders MXCT Q1 2026 Earnings EPS Beat Estimates by 5098 Despite Negative Earnings ACAD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds PNBK Q1 2019 Earnings Earnings Per Share Miss Estimates by Wide Margin Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline WMB Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Edges Higher Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss Weighs on Sentiment SELLAS Life Sciences Group SLS Gains Ground Biotech Stock Tests Key Resistance After 476 Rally Civista Bancshares CIVB Holds Near Support Amid Modest Decline Gaxosai Inc GXAI Slips 345 as Support at 106 Looms Potential Bounce or Further Weakness Neuberger Municipal Fund NBH Edges Higher in Quiet Session as Yield Hunt Continues TriNet Group TNET Edges Lower as Shares Test Key Support Levels Arbe Robotics Warrants ARBEW Surge 40 Key Levels and Outlook Palatin Technologies PTN Shows Modest Uptick Testing Key Resistance Levels Sotherly Hotels Preferred Stock SOHOB Plunges Over 8 as Support Levels Tested Duke Energy Preferred Stock DUKB Holds Steady Near Support Amid Modest Gains Salesforce CRM Edges Higher as Investors Eye Cloud Growth and Key Resistance Prediction Markets Signal Growing Odds of Fed Rate Hike by July 2027 HNVR Q1 2026 Earnings Slight EPS Miss Amid Challenging Operating Environment Propanc Biopharma PPCB Slides 69 as Weak Momentum Tests Key Support